These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 19484390)
21. Homocysteine lowering and cardiovascular disease risk: lost in translation. Marcus J; Sarnak MJ; Menon V Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392 [TBL] [Abstract][Full Text] [Related]
22. The controversial role of B-vitamins in cardiovascular risk: An update. Ntaios G; Savopoulos C; Grekas D; Hatzitolios A Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194 [TBL] [Abstract][Full Text] [Related]
23. [Homocysteine, folic acid, group B vitamins and cardiovascular risk]. Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307 [TBL] [Abstract][Full Text] [Related]
24. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults. Carlsson CM Drugs Aging; 2006; 23(6):491-502. PubMed ID: 16872232 [TBL] [Abstract][Full Text] [Related]
25. Homocysteine and cardiovascular disease: current evidence and future prospects. Mangoni AA; Jackson SH Am J Med; 2002 May; 112(7):556-65. PubMed ID: 12015248 [TBL] [Abstract][Full Text] [Related]
26. Homocysteine and risk of cardiovascular disease. Andreotti F; Burzotta F; Manzoli A; Robinson K J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184 [TBL] [Abstract][Full Text] [Related]
31. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Debreceni B; Debreceni L Cardiovasc Ther; 2012 Aug; 30(4):227-33. PubMed ID: 21884001 [TBL] [Abstract][Full Text] [Related]
32. Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk. Ikkruthi S; Rajappa M; Nandeesha H; Satheesh S; Sundar I; Ananthanarayanan PH; Harichandrakumar KT Acta Physiol Hung; 2014 Mar; 101(1):13-20. PubMed ID: 24311227 [TBL] [Abstract][Full Text] [Related]
33. Hyperhomocysteinemia: Impact on Neurodegenerative Diseases. Sharma M; Tiwari M; Tiwari RK Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):287-96. PubMed ID: 26036286 [TBL] [Abstract][Full Text] [Related]
34. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Heinz J; Kropf S; Luley C; Dierkes J Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080 [TBL] [Abstract][Full Text] [Related]